A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial for Efficacy of Acetyl-L-carnitine in Patients with Dementia Associated with Cerebrovascular Disease
- Authors
- 양영순; 최호진; 이찬녕; 김용범; YongTaeKwak
- Issue Date
- 2018
- Publisher
- 대한치매학회
- Keywords
- Acetyl-L-carnitine; Dementia; Efficacy; Vascular Cognitive Impairment; MoCA-K
- Citation
- Dementia and Neurocognitive Disorders(대한치매학회지), v.17, no.1, pp 1 - 10
- Pages
- 10
- Indexed
- KCI
- Journal Title
- Dementia and Neurocognitive Disorders(대한치매학회지)
- Volume
- 17
- Number
- 1
- Start Page
- 1
- End Page
- 10
- URI
- https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/29168
- DOI
- 10.12779/dnd.2018.17.1.1
- ISSN
- 1738-1495
- Abstract
- Background and Purpose: Acetyl-L-carnitine (ALC) is a widely used drug for various neurodegenerative diseases including dementia. The aim of the present study was to elucidate the efficacy of ALC in dementia patients with cerebrovascular disease (vascular cognitive impairment; VCI). Methods: Fifty-six patients were randomized to treatment with 500 mg ter in die ALC, or placebo in this 28-week, double-blind, placebo-controlled trial. The primary outcome measure was the Korean version of Montreal Cognitive Assessment (MoCA-K). Results: Following treatment with ALC, the cognitive function measured by the MoCA-K was significantly improved in the ALC-treated groups. However, other secondary outcomes were not statistically significant between ALC- and placebo-treated groups. In MoCA-K analysis, attention and language sub-items significantly favored the ALC-treated group. Conclusions: Compared with placebo, treatment with ALC 1,500 mg/day produced significant changes in MoCA-K in dementia patients with VCI. ALC was well tolerated in this population. Despite the study limitations, the findings suggested the potential benefits associated with the use of ALC in dementia patients with VCI.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 2. Clinical Science > Department of Neurology > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.